- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Lifeward Ltd.(LFWD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LFWD
11/13/2026: LFWD (1-star) is currently NOT-A-BUY. Pass it for now.
Lifeward Ltd. is a medical device company specializing in wearable exoskeletons and physical rehabilitation technologies like AlterG anti-gravity systems. The company features a recognized market position and established Medicare reimbursement pathways that support patient adoption across clinical and home settings. Its primary growth story centers on expanding its product pipeline and scaling reimbursement coverage globally. However, the company faces ongoing financial losses, execution risks, and competitive pressures typical of micro-cap medical device developers. Lifeward represents a speculative growth opportunity best suited for risk-tolerant investors monitoring clinical execution, cash burn, and reimbursement expansion.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Lifeward offers innovative medical technology growth drivers, but its small scale and early profitability stage present execution risks. |
| Momentum investor | Strong fit while signal remains positive | The stock can experience sharp tactical movements tied to clinical updates or reimbursement news when technical momentum turns positive. |
| Value investor | Weak fit | The company lacks current earnings and positive free cash flows, making traditional value metrics unappealing. |
| Dividend investor | Weak fit | Lifeward does not pay dividends, focusing entirely on growth and commercial expansion. |
| Low-risk investor | Weak fit | High share price volatility and micro-cap status expose low-risk investors to substantial downside risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Micro-cap medical device stocks frequently experience wide price swings based on minor operational updates. |
| Valuation risk | Medium / high | Valuation relies heavily on long-term adoption assumptions rather than near-term earnings power. |
| Competition risk (specialized medical robotics competition) | Medium / high | The company competes with well-funded competitors in developing advanced rehabilitation tech. |
| Business quality | Medium | Lifeward possesses strong proprietary products, but sustained financial self-sufficiency remains a work in progress. |
| Dividend income | Low / none | No dividend is paid to investors. |
| Execution risk | High | Successfully scaling global reimbursement and commercial sales execution is critical to financial viability. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.53M USD | Price to earnings Ratio - | 1Y Target Price 20 |
Price to earnings Ratio - | 1Y Target Price 20 | ||
Volume (30-day avg) 17.2K shares | Beta 0.56 | 52 Weeks Range 3.81 - 9.61 | Updated Date 11/15/2026 |
52 Weeks Range 3.81 - 9.61 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -15.73 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -55.62% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Exoskeleton Products | ReWalk Personal and Rehabilitation exoskeleton systems sold to institutions and qualified individual users. | Core high-ticket robotic devices that restore walking capabilities for spinal cord injury patients. |
| Rehabilitation & Wellness Devices | AlterG anti-gravity treadmills, ReStore exo-suits, and MyoCycle FES systems. | Therapy equipment sold primarily to clinics and athletic centers to assist broader physical recovery. |
| Geographic Exposure (United States & International) | Direct and distributor-led sales spanning the United States, Germany, Europe, and Asia-Pacific. | The United States serves as the primary revenue driver, supplemented by key European markets like Germany. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 9.07M | Price to Sales(TTM) 0.53 |
Enterprise Value 9.07M | Price to Sales(TTM) 0.53 | ||
Enterprise Value to Revenue 0.42 | Enterprise Value to EBITDA 1.04 | Shares Outstanding 2.84M | Shares Floating 1.57M |
Shares Outstanding 2.84M | Shares Floating 1.57M | ||
Percent Insiders 47.06 | Percent Institutions 1.37 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

